Flock, smart-money disclosures made readable

Jazz Pharmaceuticals PLC

JAZZNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+7
Gala Renee D
Jazz Pharmaceuticals PLC · NASDAQ
−2,000 sh · $472.8K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Cozadd Bruce C
Jazz Pharmaceuticals PLC · NASDAQ
−6,000 sh · $1.4M
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+30
Patil Neena M
Jazz Pharmaceuticals PLC · NASDAQ
−1,200 sh · $289.1K
Filed 14 Sept 2026SEC Form 4view source
REDUCEDStale
Gala Renee D
Jazz Pharmaceuticals PLC · NASDAQ
−1,967 sh · $485.5K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Henderson Mary Elizabeth
Jazz Pharmaceuticals PLC · NASDAQ
−15 sh · $3.6K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Henderson Mary Elizabeth
Jazz Pharmaceuticals PLC · NASDAQ
−1,412 sh · $343.2K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Gala Renee D
Jazz Pharmaceuticals PLC · NASDAQ
−2,000 sh · $486.1K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Smith Mark Douglas
Jazz Pharmaceuticals PLC · NASDAQ
−14 sh · $3.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Riedel Norbert G
Jazz Pharmaceuticals PLC · NASDAQ
−14 sh · $3.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Riedel Norbert G
Jazz Pharmaceuticals PLC · NASDAQ
−1,692 sh · $408.4K
Filed 2 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 48 disclosures

REDUCEDStale
Cook Jennifer E.
Jazz Pharmaceuticals PLC · NASDAQ
−14 sh · $3.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Love Ted W
Jazz Pharmaceuticals PLC · NASDAQ
−6 sh · $1.5K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Smith Mark Douglas
Jazz Pharmaceuticals PLC · NASDAQ
−1,692 sh · $408.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Henderson Mary Elizabeth
Jazz Pharmaceuticals PLC · NASDAQ
−16 sh · $3.9K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Kennedy Patrick
Jazz Pharmaceuticals PLC · NASDAQ
−15 sh · $3.7K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Winningham Rick E
Jazz Pharmaceuticals PLC · NASDAQ
−14 sh · $3.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Cook Jennifer E.
Jazz Pharmaceuticals PLC · NASDAQ
−1,692 sh · $408.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Enright Patrick G
Jazz Pharmaceuticals PLC · NASDAQ
−1,692 sh · $408.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Hamill Laura
Jazz Pharmaceuticals PLC · NASDAQ
−1,692 sh · $408.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Cozadd Bruce C
Jazz Pharmaceuticals PLC · NASDAQ
−1,209 sh · $291.8K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Enright Patrick G
Jazz Pharmaceuticals PLC · NASDAQ
−14 sh · $3.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Winningham Rick E
Jazz Pharmaceuticals PLC · NASDAQ
−1,692 sh · $408.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Love Ted W
Jazz Pharmaceuticals PLC · NASDAQ
−737 sh · $177.9K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
McSharry Heather Ann
Jazz Pharmaceuticals PLC · NASDAQ
−1,840 sh · $444.2K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Henderson Mary Elizabeth
Jazz Pharmaceuticals PLC · NASDAQ
−2,076 sh · $501.1K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Cozadd Bruce C
Jazz Pharmaceuticals PLC · NASDAQ
−6,000 sh · $1.5M
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
McSharry Heather Ann
Jazz Pharmaceuticals PLC · NASDAQ
−15 sh · $3.7K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Cozadd Bruce C
Jazz Pharmaceuticals PLC · NASDAQ
−10 sh · $2.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Kennedy Patrick
Jazz Pharmaceuticals PLC · NASDAQ
−1,840 sh · $444.2K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Hamill Laura
Jazz Pharmaceuticals PLC · NASDAQ
−14 sh · $3.4K
Filed 2 Sept 2026SEC Form 4view source
ACQUIREDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
+26,116 sh · $3.0M
Filed 31 Aug 2026SEC Form 4view source
REDUCEDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
−300 sh · $75.8K
Filed 31 Aug 2026SEC Form 4view source
REDUCEDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
−9,259 sh · $2.3M
Filed 31 Aug 2026SEC Form 4view source
REDUCEDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
−19,639 sh · $4.9M
Filed 31 Aug 2026SEC Form 4view source
ACQUIREDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
+884 sh · $100.0K
Filed 31 Aug 2026SEC Form 4view source
REDUCEDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
−18,113 sh · $4.5M
Filed 31 Aug 2026SEC Form 4view source
REDUCEDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
−18,187 sh · $4.5M
Filed 31 Aug 2026SEC Form 4view source
REDUCEDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
−11,423 sh · $2.8M
Filed 31 Aug 2026SEC Form 4view source
ACQUIREDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
+2,916 sh · $399.8K
Filed 31 Aug 2026SEC Form 4view source
ACQUIREDStale
Iannone Robert
Jazz Pharmaceuticals PLC · NASDAQ
+27,584 sh · $3.8M
Filed 31 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
Jazz Pharmaceuticals PLC · NASDAQ
562,073 sh · $135.4M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Polen Capital Management
Jazz Pharmaceuticals PLC · NASDAQ
1,858 sh · $447.7K
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Jazz Pharmaceuticals PLC · NASDAQ
19,600 sh · $3.7M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Jazz Pharmaceuticals PLC · NASDAQ
819,374 sh · $154.9M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Jazz Pharmaceuticals PLC · NASDAQ
836,774 sh · $142.3M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Jazz Pharmaceuticals PLC · NASDAQ
924,874 sh · $121.9M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Jazz Pharmaceuticals PLC · NASDAQ
900,368 sh · $95.5M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Jazz Pharmaceuticals PLC · NASDAQ
6,145,758 sh · $655.9M
Filed 30 Jun 2024SEC 13Fview source